Director, Molecular & Cellular Immunology
Stylus Medicine
This listing was originally posted on Stylus Medicine's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAbout Stylus Medicine:
Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics. The company’s approach is versatile and modular, with potential therapeutic application across oncology, autoimmune, genetic diseases, and beyond.
About the Role:
Stylus Medicine is seeking an innovative, intellectually curious, and team-oriented Director, Molecular & Cellular Immunology to apply their deep immunology expertise and problem-solving abilities to collaboratively develop non-viral in vivo CART therapies. Reporting to the SVP, Immunology, this individual will lead the Molecular & Cellular Immunology team, with accountability for the execution of in vitro workflows in support of deepening our mechanistic understanding of the Stylus platform applied to immune cells, innovating within the platform, progressing the lead CART program to development candidate nomination, and preparing for advancement to clinic. This role is expected to serve as a close scientific thought partner with the SVP of Immunology, an effective collaborator with members of the broader scientific team, and a key driver in our mission to revolutionize the field of in vivo immune therapy.
Key Responsibilities & Accountabilities:
Qualifications & Skills:
Pay Range: $225,000-$240,000
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Stylus Medicine?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Enzymatic Gene Therapy
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo